Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin

Journal of Immunology

Volumn 180, Issue 6, 2008, Pages 4000-4010

  Wakabayashi, Ayako ^a   Nakagawa, Yohko ^a   Shimizu, Masumi ^a   Moriya, Keiichi ^a   Nishiyama, Yasuhiro ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8ALPHA ANTIGEN; CD8ALPHAALPHA ANTIGEN; CD8ALPHABETA ANTIGEN; CHOLERA TOXIN; CHOLERA TOXIN A SUBUNIT; CHOLERA TOXIN B SUBUNIT; OVALBUMIN; PROTEIN SUBUNIT; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; C57BL 6 MOUSE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HISTOPATHOLOGY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; SPLEEN CELL; STOMACH TUMOR; T LYMPHOCYTE ACTIVATION; THYMOCYTE; THYMUS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; CYTOTOXICITY; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUTH MUCOSA; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD8; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CHOLERA TOXIN; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MOUTH MUCOSA; OVALBUMIN; SKIN NEOPLASMS; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 44849092687     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.6.4000     Document Type: Article

References (52)

1. Franks, L. M., and M. A. Knowles. 2005. What is cancer? In Introduction to the Cellular and Molecular Biology of Cancer, 4th Ed. M. A. Knowles and P. J. Selby, eds. Oxford University Press, New York, pp. 1-24.
2. Finn, O. J. 2003. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 3: 630-641.
3. Czerkinsky, C., F. Anjuere, J. R. McGhee, A. George-Chandy, J. Holmgren, M. P. Kieny, K. Fujiyashi, J. F. Mestecky, V. Pierrefite-Carle, C. Rask, and J. B. Sun. 1999. Mucosal immunity and tolerance: relevance to vaccine development. Immunol. Rev. 170: 197-222.
4. Yuki, Y., and H. Kiyono. 2003. New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 13: 293-310.
5. Takahashi, H. 2003. Antigen presentation in vaccine development. Comp. Immunol. Microbiol. Infect. Dis. 26: 309-328.
6. Hayday, A., E. Theodoridis, E. Ramsburg, and J. Shires. 2001. Intraepithelial lymphocytes: exploring the third way in immunology. Nat. Immunol. 2: 997-1003.
7. Offit, P. A., and K. I. Dudzik. 1989. Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J. Virol. 63: 3507-3512.
8. + gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J. Immunol. 153: 4596-4603.
9. Muller, S., M. Buhler-Jungo, and C. Mueller. 2000. Intestinal intraepithelial lymphocytes exert potent protective cytotoxic activity during an acute virus infection. J. Immunol. 164: 1986-1994.
10. Taunk, J., A. I. Roberts, and E. C. Ebert. 1992. Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors. Gastroenterology 102: 69-75.
11. Roberts, A. I., S. M. O'Connell, L. Biancone, R. E. Brolin, and E. C. Ebert. 1993. Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism. Clin. Exp. Immunol. 94: 527-532.
12. Kuribayashi, H., A. Wakabayashi, M. Shimizu, H. Kaneko, Y. Norose, Y. Nakagawa, J. Wang, Y. Kumagai, D. H. Margulies, and H. Takahashi. 2004. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice. Biochem. Biophys. Res. Commun. 316: 356-363.
13. Takahashi, H., J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. L. Cornette, C. DeLisi, B. Moss, R. N. Germain, and J. A. Berzofsky. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 85: 3105-3109.
14. Williams, N. A., T. R. Hirst, and T. O. Nashar. 1999. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today 20: 95-101.
15. Lencer, W. I., and B. Tsai. 2003. The intracellular voyage of cholera toxin: going retro. Trends Biochem. Sci. 28: 639-645.
16. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132: 2736-2741.
17. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155: 4621-4629.
18. Bowen, J. C., S. K. Nair, R. Reddy, and B. T. Rouse. 1994. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 81: 338-342.
19. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169: 603-612.
20. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
21. Porgador, A., H. F. Staats, B. Faiola, E. Gilboa, and T. J. Palker. 1997. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J. Immunol. 158: 834-841.
22. + T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC. J. Immunol. 165: 6731-6737.
23. Eriksson, K., J. B. Sun, I. Nordstrom, M. Fredriksson, M. Lindblad, B. L. Li, and J. Holmgren. 2004. Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor. Eur. J. Immunol. 34: 1272-1281.
24. + T cells that secrete IFN-γ and IL-5. J. Immunol. 145: 68-77.
25. + HIV-1 envelope-specific murine CTLs by short exposure to antigenic peptide. J. Immunol. 169: 6588-6593.
26. Semple, J. W., and M. R. Szewczuk. 1986. Natural killer cells in murine muscular dystrophy: IV. Characterization of Percoll fractionated splenic and thymic natural killer cells and natural killer-sensitive thymocyte targets. Clin. Immunol. Immunopathol. 41: 116-129.
27. + T cell responses. J. Immunol. 166: 4627-4633.
28. Nakatsuka, K., H. Sugiyama, Y. Nakagawa, and H. Takahashi. 1999. Purification of antigenic peptide from murine hepatoma cells recognized by class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells. J. Hepatol. 30: 1119-1129.
29. Kilshaw, P. J., and K. C. Baker. 1988. A unique surface antigen on intraepithelial lymphocytes in the mouse. Immunol. Lett. 18: 149-154.
30. Russell, G. J., C. M. Parker, K. L. Cepek, D. A. Mandelbrot, A. Sood, E. Mizoguchi, E. C. Ebert, M. B. Brenner, and A. K. Bhan. 1994. Distinct structural and functional epitopes of the α E β 7 integrin. Eur. J. Immunol. 24: 2832-2841.
31. Lefrancois, L., T. A. Barrett, W. L. Havran, and L. Puddington. 1994. Developmental expression of the α IEL β 7 integrin on T cell receptor γ δ and T cell receptor α β T cells. Eur. J. Immunol. 24: 635-640.
32. Rocha, B., P. Vassalli, and D. Guy-Grand. 1994. Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J. Exp. Med. 180: 681-686.
33. Wakabayashi, A., Y. Kumagai, E. Watari, M. Shimizu, M. Utsuyama, K. Hirokawa, and H. Takahashi. 2006. Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction. Immunology 119: 167-177.
34. + cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells. Clin. Immunol. 112: 35-44.
35. + cytotoxic T lymphocytes. Int. Immunol. 16: 55-63.
36. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433: 887-892.
37. Kawamura, Y. I., R. Kawashima, Y. Shirai, R. Kato, T. Hamabata, M. Yamamoto, K. Furukawa, K. Fujihashi, J. R. McGhee, H. Hayashi, and T. Dohi. 2003. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-κB translocation. Eur. J. Immunol. 33: 3205-3212.
38. Gagliardi, M. C., F. Sallusto, M. Marinaro, A. Langenkamp, A. Lanzavecchia, and M. T. De Magistris. 2000. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30: 2394-2403.
39. Grdic, D., L. Ekman, K. Schon, K. Lindgren, J. Mattsson, K. E. Magnusson, P. Ricciardi-Castagnoli, and N. Lycke. 2005. Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin. J. Immunol. 175: 5192-5202.
40. Shreedhar, V. K., B. L. Kelsall, and M. R. Neutra. 2003. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 71: 504-509.
41. Drakes, M. L., S. J. Czinn, and T. G. Blanchard. 2006. Regulation of murine dendritic cell immune responses by Helicobacter felis antigen. Infect. Immun. 74: 4624-4633.
42. 7-integrin- positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice. Gastroenterology 119: 109-118.
43. 7 integrins in CD8 T cell trafficking during an antiviral immune response. J. Exp. Med. 189: 1631-1638.
44. 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80: 413-422.
45. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74: 185-195.
46. Streeter, P. R., E. L. Berg, B. T. Rouse, R. F. Bargatze, and E. C. Butcher. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331: 41-46.
47. Lindholm, C., A. Naylor, E. L. Johansson, and M. Quiding-Jarbrink. 2004. Mucosal vaccination increases endothelial expression of mucosal addressin cell adhesion molecule 1 in the human gastrointestinal tract. Infect. Immun. 72: 1004-1009.
48. + T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect. Immun. 73: 5612-5619.
49. Belyakov, I. M., S. A. Hammond, J. D. Ahlers, G. M. Glenn, and J. A. Berzofsky. 2004. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113: 998-1007.
50. Clarke, L. L., B. R. Grubb, S. E. Gabriel, O. Smithies, B. H. Koller, and R. C. Boucher. 1992. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 257: 1125-1128.
51. Yamamoto, S., Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee. 1997. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 185: 1203-1210.
52. Maghazachi, A. A., A. Al-Aoukaty, C. Naper, K. M. Torgersen, and B. Rolstad. 1996. Preferential involvement of Go and Gz proteins in mediating rat natural killer cell lysis of allogeneic and tumor target cells. J. Immunol. 157: 5308 -5314.